GS-441524 powder is a form of the antiviral medication used in the treatment of Feline Infectious Peritonitis (FIP), a deadly disease in cats caused by a mutation of the feline coronavirus. This powder can be reconstituted with a specific solvent to create either an injectable solution or an oral suspension, providing flexibility in administration based on the cat's needs and health condition. As a nucleoside analog, GS-441524 works by inhibiting the virus's RNA polymerase, thus preventing the virus from replicating and reducing the viral load in the cat's body. The powder form allows for precise customization of dosage, making it suitable for cats of various sizes and disease severities. While GS-441524 powder is not officially approved in many countries, it has become a crucial option for veterinarians and pet owners seeking to treat FIP, offering hope and potential recovery in cases that were once considered untreatable. Proper preparation and handling are essential to ensure the medication's efficacy and safety.
Property | Details |
---|---|
CAS Number | 1191237-69-0 |
Grade | Pharmaceutcial Grade |
Shipping Method | Air(UPS, FedEx, TNT, EMS) Or Sea |
Density | 1.84±0.1 G |
Appearance | White Powder |
Storage | Store At Cool Dry Place |
Molecular Weight | 291.26 |
Purity |
99.0% |
Feline Infectious Peritonitis (FIP) is a fatal viral disease in cats caused by a mutation of the feline coronavirus (FCoV). While most cats infected with FCoV do not develop FIP, in some cases, the virus mutates and triggers an abnormal immune response, leading to FIP.
FCoV is common in multi-cat environments like shelters and catteries. The virus is primarily transmitted through fecal-oral contact, where cats ingest the virus from contaminated surfaces, litter boxes, or grooming each other.
GS441524 is a medication used to treat feline infectious peritonitis (FIP). Below are the general guidelines for using GS441524 powder, but specific usage should be adjusted according to a veterinarian's instructions:
1. Dosage:
The typical dosage depends on the cat's weight and the severity of the condition. The recommended dosage is usually 4-6 mg/kg of body weight, but higher doses may be required for severe cases.
2. Preparation:
GS441524 powder needs to be dissolved in sterile water or another appropriate solvent. Preparation should be done in a clean, sterile environment to ensure the stability and effectiveness of the medication.
3. Injection:
The dissolved solution is usually administered via subcutaneous or intravenous injection. For subcutaneous injection, choose a soft skin area (such as the back or shoulder) and use a sterile syringe. Intravenous injection should be performed by a professional veterinarian.
4. Frequency and Duration:
Generally, the injection is given once daily for at least 12 weeks. During the treatment, regular blood tests and other diagnostic evaluations are necessary to monitor the treatment's effectiveness and adjust the dosage as needed.
5. Precautions:
Ensure all equipment (syringes, solvents, etc.) is sterile.
Avoid overdosing to prevent potential toxicity and side effects.
If any adverse reactions occur during treatment, contact a veterinarian immediately.
The specific method and dosage should be determined and adjusted by a veterinarian based on the cat's condition. Always consult a professional veterinarian and follow their instructions precisely when using GS441524 powder.